Quinoline derivatives as phosphodiesterase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 417/12 (2006.01) A61K 31/4706 (2006.01) A61K 31/4709 (2006.01) A61P 11/00 (2006.01) C07D 215/54 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07D 403/14 (2006.01) C07D 407/12 (2006.01) C07D 407/14 (2006.01) C07D 409/12 (2006.01) C07D 413/12 (2006.01)

Patent

CA 2526228

There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20 and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.

L'invention concerne des nouveaux composés de formule (I) ou des sels de ceux-ci, acceptables au plan pharmaceutique, formule dans laquelle R1, R2, R19, R20 et R34 sont tels que décrits dans la spécification, leurs procédés de préparation, des formules les contenant et leur utilisation thérapeutiques pour le traitement de maladies inflammatoires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Quinoline derivatives as phosphodiesterase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinoline derivatives as phosphodiesterase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline derivatives as phosphodiesterase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2012428

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.